These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8288012)

  • 1. Management of severe, early pre-eclampsia: is conservative management justified?
    Oláh KS; Redman CW; Gee H
    Eur J Obstet Gynecol Reprod Biol; 1993 Oct; 51(3):175-80. PubMed ID: 8288012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expectant management of early onset, severe pre-eclampsia: perinatal outcome.
    Hall DR; Odendaal HJ; Kirsten GF; Smith J; Grové D
    BJOG; 2000 Oct; 107(10):1258-64. PubMed ID: 11028578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial.
    Sibai BM; Mercer BM; Schiff E; Friedman SA
    Am J Obstet Gynecol; 1994 Sep; 171(3):818-22. PubMed ID: 8092235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expectant management of severe pre-eclampsia in the mid-trimester.
    Hall DR; Odendaal HJ; Steyn DW
    Eur J Obstet Gynecol Reprod Biol; 2001 Jun; 96(2):168-72. PubMed ID: 11384801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early onset severe pre-eclampsia: expectant management at a secondary hospital in close association with a tertiary institution.
    Oettle C; Hall D; Roux A; Grové D
    BJOG; 2005 Jan; 112(1):84-8. PubMed ID: 15663403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a definition of pre-eclampsia.
    North RA; Taylor RS; Schellenberg JC
    Br J Obstet Gynaecol; 1999 Aug; 106(8):767-73. PubMed ID: 10453825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of fetal growth restriction on latency in the setting of expectant management of preeclampsia.
    McKinney D; Boyd H; Langager A; Oswald M; Pfister A; Warshak CR
    Am J Obstet Gynecol; 2016 Mar; 214(3):395.e1-7. PubMed ID: 26767794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expectant management of severe preeclampsia presenting before 25 weeks of gestation.
    Sezik M; Ozkaya O; Sezik HT; Yapar EG
    Med Sci Monit; 2007 Nov; 13(11):CR523-527. PubMed ID: 17968301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteinuria in pre-eclampsia: how much matters?
    Chan P; Brown M; Simpson JM; Davis G
    BJOG; 2005 Mar; 112(3):280-5. PubMed ID: 15713140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservative management of early-onset pre-eclampsia and fetomaternal outcome in Nigerians.
    Onah HE; Iloabachie GC
    J Obstet Gynaecol; 2002 Jul; 22(4):357-62. PubMed ID: 12521453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort study.
    Hawkins TL; Roberts JM; Mangos GJ; Davis GK; Roberts LM; Brown MA
    BJOG; 2012 Mar; 119(4):484-92. PubMed ID: 22251368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expectant management of early onset, severe pre-eclampsia: maternal outcome.
    Hall DR; Odendaal HJ; Steyn DW; Grové D
    BJOG; 2000 Oct; 107(10):1252-7. PubMed ID: 11028577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Morbidity and mortality of patients with preeclampsia or HELLP syndrome transferred in intensive care].
    Sabbah-Briffaut E; Bourzoufi K; Fourrier F; Subtil D; Houfflin-Debarge V; Deruelle P
    Presse Med; 2009 Jun; 38(6):872-80. PubMed ID: 19186027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial.
    Koopmans CM; Bijlenga D; Groen H; Vijgen SM; Aarnoudse JG; Bekedam DJ; van den Berg PP; de Boer K; Burggraaff JM; Bloemenkamp KW; Drogtrop AP; Franx A; de Groot CJ; Huisjes AJ; Kwee A; van Loon AJ; Lub A; Papatsonis DN; van der Post JA; Roumen FJ; Scheepers HC; Willekes C; Mol BW; van Pampus MG;
    Lancet; 2009 Sep; 374(9694):979-988. PubMed ID: 19656558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Conservative management in severe pre-eclampsia].
    Romero Arauz JF; Lara González AL; Izquierdo Puente C
    Ginecol Obstet Mex; 2000 Feb; 68():51-4. PubMed ID: 10774104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perinatal outcomes in preeclampsia that is complicated by massive proteinuria.
    Newman MG; Robichaux AG; Stedman CM; Jaekle RK; Fontenot MT; Dotson T; Lewis DF
    Am J Obstet Gynecol; 2003 Jan; 188(1):264-8. PubMed ID: 12548227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of proteinuria in defining pre-eclampsia: clinical outcomes for women and babies.
    Thornton CE; Makris A; Ogle RF; Tooher JM; Hennessy A
    Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):466-70. PubMed ID: 19930427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal and perinatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven year experience of a tertiary care center.
    Yücesoy G; Ozkan S; Bodur H; Tan T; Calişkan E; Vural B; Corakçi A
    Arch Gynecol Obstet; 2005 Nov; 273(1):43-9. PubMed ID: 15834580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal and fetal outcome in women with hypertensive disorders of pregnancy: the impact of prenatal care.
    Barbosa IR; Silva WB; Cerqueira GS; Novo NF; Almeida FA; Novo JL
    Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):140-6. PubMed ID: 26220808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications.
    Rotchell YE; Cruickshank JK; Gay MP; Griffiths J; Stewart A; Farrell B; Ayers S; Hennis A; Grant A; Duley L; Collins R
    Br J Obstet Gynaecol; 1998 Mar; 105(3):286-92. PubMed ID: 9532988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.